Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiang Peng
Observed name:
Peng, Xiang
Institutions:
Sun Yat-sen University,
Sixth Affiliated Hospital of Sun Yat-sen University
Observed institutions:
Sun Yat-sen University,
Sixth Affiliated Hospital of Sun Yat-sen University,
Key Laboratory of Guangdong Province
ORCID:
0000-0001-5285-9413
Observed ORCID:
0000-0001-5285-9413
OpenAlex ID:
A5084944706
Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study
2023
·
Xiang Peng
, Huang-wei Chen
, et al.
·
Clinical and Experimental Medicine
·
48
PDF
Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Study
2024
·
Xiang Peng
, Jia-Yin Yao
, et al.
·
Clinical Gastroenterology and Hepatology
·
32
Computed tomography‐based radiomics nomogram using machine learning for predicting 1‐year surgical risk after diagnosis of Crohn's disease
2023
·
Jiayin Yao
, Jie Zhou
, et al.
·
Medical Physics
·
16
PDF
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
2022
·
Jun-Zhang Zhao
, Wei Wang
, et al.
·
BMC Cancer
·
12
PDF
HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn’s disease
2023
·
Wei Wang
, Qi Zhang
, et al.
·
Gastroenterology report
·
10
PDF
Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial
2026
·
Jiayin Yao
, Hongzhen Wu
, et al.
·
Clinical Gastroenterology and Hepatology
XIAP Deficiency Impairs Colonic Tuft Cell Development and Predisposes to Crohn's Disease
2026
·
Rongli Fang
, Wei Wang
, et al.
·
MedComm
Tu1865: EFFICACY AND SAFETY OF DIFFERENT DOSES OF ADALIMUMAB IN CROHN’S DISEASE: A MULTICENTER COHORT STUDY IN INFLIXIMABNAIVE AND INFLIXIMAB-EXPOSED PATIENTS
2025
·
Zhaoyuan Xu
, Xiang Peng
, et al.
·
Gastroenterology
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
2022
·
Jun-Zhang Zhao
, Wei Wang
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
20
Citation count:
118
H-index:
5
I10-index:
5
Year
Topic
Type